Anthropic IPO: Why There Could Be More Than One AI Winner

Anthropic's IPO is expected in the week of Nov. 16, while OpenAI has said it intends to defer a potential IPO until 2027. The article argues both companies could benefit as the global AI market grows from just over $707 billion this year to an estimated $1.9 trillion by 2032; U.S. business AI adoption reached 24.6% in October 2026, up from 3.7% in September 2023. It presents owning both companies as a possible way to participate in the trend, while noting competition and portfolio concentration risk.

Analysis

The “large market means two winners” argument is directionally plausible but not sufficient for an IPO buy: aggregate AI-market forecasts are not a measure of the addressable market or profit pool for foundation-model vendors. Broader adoption could benefit both Anthropic and OpenAI while pushing enterprises toward multi-model procurement, making model performance less differentiating and pricing, switching costs, and distribution more decisive. That can shift value toward cloud platforms and compute suppliers while pressuring model-layer economics through inference costs and price competition.

Near term, an IPO may attract scarcity-driven demand, but that is a positioning event, not evidence of durable returns. Over 1–3 months, focus on the offer valuation, float and selling restrictions, customer concentration, gross-margin trajectory, inference expense, and the terms of cloud/computing commitments. Over 6–18 months, watch whether enterprise usage converts into recurring revenue and improving unit economics rather than merely rising usage. The article’s adoption and market-size figures do not establish either outcome.

Contrarian angle: investors may overvalue the idea that both companies can prosper just because the category grows. The key risk is that both gain usage but neither captures attractive margins. OpenAI’s delayed IPO also makes a clean public-market pair trade unavailable for now. No unconditional IPO purchase is warranted without valuation and financial disclosures.

Key Decisions for Investors

• Treat ANT as a valuation-dependent event, not an automatic AI-growth allocation. Consider only a staged position after reviewing offer valuation, float, audited revenue, gross margins, and inference costs; do not infer attractive economics from market-size forecasts.
• Set a 1–3 month diligence alert for evidence of enterprise revenue conversion, renewal rates, customer concentration, and cloud/computing commitments. If usage expands but gross margins deteriorate or guidance indicates persistent high inference costs, avoid or reduce exposure.
• Do not attempt an ANT/OpenAI pair trade until OpenAI is publicly investable. Reassess when its timing and disclosures are known; meanwhile, model multi-vendor adoption as a scenario, not a hedge.
• Falsify the constructive thesis if disclosures show weak recurring monetization, worsening unit economics, or customer dependence that leaves the business exposed to renegotiation; absent those data, the disciplined action is to watch rather than chase first-day pricing.